{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:51:47Z","timestamp":1782953507241,"version":"3.54.5"},"reference-count":88,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>In this study, the authors sought to define the differences in the incidence of delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated with placebo. Secondary objectives were to define the clinical outcome at discharge and 3 months and the incidence of brain infarction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A prospective, randomized, double-blind, placebo-controlled study was performed and included patients with aneurysmal subarachnoid hemorrhage (SAH) within 5 days from ictus who were candidates for aneurysm occlusion, and who had a Fisher grade of 3 or 4. Patients with sulfa or sulfone drug allergies, hemoglobin &lt; 11 g\/dl, known G6PD deficiency, and those refusing informed consent were excluded. A minimal relevant effect decrease of 35% in the incidence of DCI was established. Patients were randomly assigned to receive a regimen of dapsone 2.5 ml (100 mg) daily or a placebo (aluminum hydroxide suspension, 2.5 ml daily). Both groups received validated treatment for aneurysmal SAH. The appearance of DCI on CT was assessed in every patient at discharge and 3 months later. We used the chi-square test to compare the DCI incidence between both groups, and the Student t-test or nonparametric tests to compare quantitative variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Overall, 48 patients (70.8% women and 29.2% men) were included. The mean age was 50 years (SD 14.28 years, range 18\u201372 years). Prerandomization and postrandomization characteristics were balanced, except for the necessity of intra-arterial nimodipine administration in patients treated with placebo (15.4% vs 45.5%, p = 0.029. The incidence of DCI, the primary endpoint, for the whole cohort was 43.8% and was significantly lower in the dapsone group (26.9% vs 63.6%, p = 0.011). In addition, the irreversible DCI incidence was lower in the dapsone group (11.5% vs 54.5%, p = 0.12). A favorable modified Rankin Scale score was more frequent in the dapsone group at discharge and at 3 months (76.9% vs 36.4%, p = 0.005 and 80% vs 38.9%, p = 0.019, respectively). Also, the brain infarction incidence was lower in the dapsone group (19.2% vs 63.6%, p = 0.001). There was no difference between groups regarding adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Dapsone seems to play a role as a prophylactic agent in patients at high risk of developing DCI after aneurysmal SAH. A multicenter investigation is necessary to increase the study population and confirm the consistency of the results observed in this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2021.12.focus21663","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T07:20:16Z","timestamp":1646119216000},"page":"E12","source":"Crossref","is-referenced-by-count":13,"title":["Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.3171","volume":"52","author":[{"given":"Cuauht\u00e9moc","family":"Garc\u00eda-Pastor","sequence":"first","affiliation":[{"name":"Neurosurgery Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Navarro-Garcia de Llano","sequence":"additional","affiliation":[{"name":"Neurosurgery Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Balc\u00e1zar-Padr\u00f3n","sequence":"additional","affiliation":[{"name":"Neurosurgery Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Trist\u00e1n-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Neurochemistry Department, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda \u201cManuel Velasco Su\u00e1rez,\u201d Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Rios","sequence":"additional","affiliation":[{"name":"Neurochemistry Department, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda \u201cManuel Velasco Su\u00e1rez,\u201d Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"D\u00edaz-Ru\u00edz","sequence":"additional","affiliation":[{"name":"Neurochemistry Department, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda \u201cManuel Velasco Su\u00e1rez,\u201d Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Rodr\u00edguez-Hernandez","sequence":"additional","affiliation":[{"name":"Neurosurgery Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Nathal","sequence":"additional","affiliation":[{"name":"Neurosurgery Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"Neurol India","first-page":"185","article-title":"Cerebral vasospasm and delayed cerebral ischemia: review of literature and the management approach","volume":"67","author":"Chugh C","year":"2019","unstructured":"Chugh C, Agarwal H. Cerebral vasospasm and delayed cerebral ischemia: review of literature and the management approach. Neurol India. 2019;67(1):185\u2013200.30860121"},{"issue":"6","key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3171\/jns.2003.98.6.1222","article-title":"Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"98","author":"McGirt MJ","year":"2003","unstructured":"McGirt MJ, Mavropoulos JC, McGirt LY,  Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(6):1222\u20131226.10.3171\/jns.2003.98.6.122212816268"},{"issue":"3","key":"b3","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1227\/01.NEU.0000153925.96889.8A","article-title":"Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study","volume":"56","author":"Parra A","year":"2005","unstructured":"Parra A, Kreiter KT, Williams S,  Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery. 2005;56(3):476\u2013484.10.1227\/01.NEU.0000153925.96889.8A15730572"},{"issue":"8","key":"b4","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","article-title":"Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial","volume":"36","author":"Tseng MY","year":"2005","unstructured":"Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36(8):1627\u20131632.1604919910.1161\/01.STR.0000176743.67564.5d"},{"key":"b5","series-title":"J Neurol Sci","doi-asserted-by":"publisher","first-page":"116539","DOI":"10.1016\/j.jns.2019.116539","article-title":"Impaired cerebrovascular reactivity may predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"407","author":"B\u00f8thun ML","year":"2019","unstructured":"B\u00f8thun ML, Haaland \u00d8A, Moen G,  Impaired cerebrovascular reactivity may predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2019;407:116539.3166972510.1016\/j.jns.2019.116539"},{"key":"b6","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e913","DOI":"10.1016\/j.wneu.2020.03.146","article-title":"Cerebral vasospasm after spontaneous subarachnoid hemorrhage: angiographic pattern and its impact on the clinical course","volume":"138","author":"Ditz C","year":"2020","unstructured":"Ditz C, Leppert J, Neumann A,  Cerebral vasospasm after spontaneous subarachnoid hemorrhage: angiographic pattern and its impact on the clinical course. World Neurosurg. 2020;138:e913\u2013e921.10.1016\/j.wneu.2020.03.14632247799"},{"issue":"4","key":"b7","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1227\/01.NEU.0000137628.51839.D5","article-title":"Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage","volume":"55","author":"Hoh BL","year":"2004","unstructured":"Hoh BL, Topcuoglu MA, Singhal AB,  Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55(4):779\u2013789.1545858610.1227\/01.NEU.0000137628.51839.D5"},{"issue":"2","key":"b8","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00701-018-3765-8","article-title":"How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?","volume":"161","author":"Hollingworth M","year":"2019","unstructured":"Hollingworth M, Jamjoom AAB, Bulters D, Patel HC. How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?. Acta Neurochir (Wien). 2019;161(2):385\u2013392.10.1007\/s00701-018-3765-8"},{"key":"b9","series-title":"Acta Neurochir Suppl","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/3-211-27911-3_11","article-title":"Cerebral vasospasm: results of a structured multimodal treatment","volume":"94","author":"Keller E","year":"2005","unstructured":"Keller E, Krayenb\u00fchl N, Bjeljac M, Yonekawa Y. Cerebral vasospasm: results of a structured multimodal treatment. Acta Neurochir Suppl. 2005;94:65\u201373.1606024310.1007\/3-211-27911-3_11"},{"issue":"9","key":"b10","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","article-title":"Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited","volume":"32","author":"Claassen J","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K,  Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32(9):2012\u20132020.10.1161\/hs0901.09567711546890"},{"issue":"4","key":"b11","series-title":"Crit Care Med","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/00003246-200004000-00012","article-title":"Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"28","author":"Qureshi AI","year":"2000","unstructured":"Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA. Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med. 2000;28(4):984\u2013990.1080927010.1097\/00003246-200004000-00012"},{"issue":"1","key":"b12","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/neuros\/nyx364","article-title":"The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes","volume":"83","author":"Ahn SH","year":"2018","unstructured":"Ahn SH, Savarraj JP, Pervez M,  The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes. Neurosurgery. 2018;83(1):137\u2013145.10.1093\/neuros\/nyx36428973675"},{"issue":"6","key":"b13","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/jnnp.2003.033068","article-title":"Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?","volume":"75","author":"Goddard AJ","year":"2004","unstructured":"Goddard AJ, Raju PP, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?. J Neurol Neurosurg Psychiatry. 2004;75(6):868\u2013872.1514600210.1136\/jnnp.2003.033068"},{"issue":"2","key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2016.10.JNS16748","article-title":"Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis","volume":"129","author":"Dasenbrock HH","year":"2018","unstructured":"Dasenbrock HH, Rudy RF, Rosalind Lai PM,  Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis. J Neurosurg. 2018;129(2):446\u2013457.10.3171\/2016.10.JNS1674829076779"},{"issue":"4","key":"b15","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0230953","DOI":"10.1371\/journal.pone.0230953","article-title":"Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older","volume":"15","author":"Ido K","year":"2020","unstructured":"Ido K, Kurogi R, Kurogi A,  Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. PLoS One. 2020;15(4):e0230953.10.1371\/journal.pone.023095332271814"},{"issue":"6","key":"b16","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2176\/nmc.oa.2013-0169","article-title":"Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"54","author":"Inagawa T","year":"2014","unstructured":"Inagawa T, Yahara K, Ohbayashi N. Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2014;54(6):465\u2013473.10.2176\/nmc.oa.2013-0169"},{"issue":"2","key":"b17","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainres.2003.11.040","article-title":"Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats","volume":"999","author":"R\u00edos C","year":"2004","unstructured":"R\u00edos C, Nader-Kawachi J, Rodriguez-Pay\u00e1n AJ, Nava-Ruiz C. Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats. Brain Res. 2004;999(2):212\u2013215.10.1016\/j.brainres.2003.11.040"},{"issue":"1","key":"b18","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0090-3019(97)00508-9","article-title":"Effect of clot removal and surgical manipulation on regional cerebral blood flow and delayed vasospasm in early aneurysm surgery for subarachnoid hemorrhage","volume":"51","author":"Hosoda K","year":"1999","unstructured":"Hosoda K, Fujita S, Kawaguchi T, Shose Y, Hamano S, Iwakura M. Effect of clot removal and surgical manipulation on regional cerebral blood flow and delayed vasospasm in early aneurysm surgery for subarachnoid hemorrhage. Surg Neurol. 1999;51(1):81\u201388.10.1016\/S0090-3019(97)00508-99952128"},{"issue":"7","key":"b19","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/01.STR.30.7.1409","article-title":"Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans","volume":"30","author":"Thomas JE","year":"1999","unstructured":"Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke. 1999;30(7):1409\u20131416.1039031510.1161\/01.STR.30.7.1409"},{"issue":"8","key":"b20","series-title":"Eur Radiol","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s00330-016-4702-y","article-title":"Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis","volume":"27","author":"Boulouis G","year":"2017","unstructured":"Boulouis G, Labeyrie MA, Raymond J,  Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol. 2017;27(8):3333\u20133342.10.1007\/s00330-016-4702-y28004163"},{"key":"b21","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.wneu.2019.03.083","article-title":"A Review of the Management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"126","author":"Li K","year":"2019","unstructured":"Li K, Barras CD, Chandra RV,  A Review of the Management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513\u2013527.3089874010.1016\/j.wneu.2019.03.083"},{"issue":"2","key":"b22","series-title":"Platelets","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/09537104.2014.886677","article-title":"Dapsone for immune thrombocytopenic purpura in children and adults","volume":"26","author":"Patel AP","year":"2015","unstructured":"Patel AP, Patil AS. Dapsone for immune thrombocytopenic purpura in children and adults. Platelets. 2015;26(2):164\u2013167.10.3109\/09537104.2014.88667724512442"},{"issue":"2)(suppl 1","key":"b23","series-title":"An Bras Dermatol","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1590\/abd1806-4841.2019940206","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus\u2014Brazilian Society of Dermatology","volume":"94","author":"Porro AM","year":"2019","unstructured":"Porro AM, Hans Filho G, Santi CG. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus\u2014Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2)(suppl 1):20\u201332.10.1590\/abd1806-4841.201994020631166407"},{"issue":"8","key":"b24","series-title":"Eur J Pediatr","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00431-019-03409-5","article-title":"Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature","volume":"178","author":"Roman C","year":"2019","unstructured":"Roman C, Dima B, Muyshont L, Schurmans T, Gilliaux O. Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. Eur J Pediatr. 2019;178(8):1275\u20131281.10.1007\/s00431-019-03409-5"},{"issue":"5","key":"b25","series-title":"Br J Dermatol","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2133.2005.06559.x","article-title":"Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner","volume":"152","author":"Suda T","year":"2005","unstructured":"Suda T, Suzuki Y, Matsui T,  Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol. 2005;152(5):887\u2013895.10.1111\/j.1365-2133.2005.06559.x"},{"key":"b26","series-title":"Malar J","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-11-139","article-title":"Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria","volume":"11","author":"Van Malderen C","year":"2012","unstructured":"Van Malderen C, Van Geertruyden JP, Machevo S,  Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J. 2012;11:139.10.1186\/1475-2875-11-139"},{"issue":"4","key":"b27","series-title":"Electrophysiologic evaluation. Arch Med Res","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0188-4409(03)00045-6","article-title":"Anticonvulsant activity of dapsone analogs","volume":"34","author":"L\u00f3pez-Naranjo F","year":"2003","unstructured":"L\u00f3pez-Naranjo F, Casta\u00f1eda-L\u00f3pez C, Rojas-Oviedo I,  Anticonvulsant activity of dapsone analogs. Electrophysiologic evaluation. Arch Med Res. 2003;34(4):269\u2013272.10.1016\/S0188-4409(03)00045-612957521"},{"issue":"11","key":"b28","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/jnnp.51.11.1457","article-title":"A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies","volume":"51","author":"Teasdale GM","year":"1988","unstructured":"Teasdale GM, Drake CG, Hunt W,  A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51(11):1457.323602410.1136\/jnnp.51.11.1457"},{"issue":"1","key":"b29","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","author":"Fisher CM","year":"1980","unstructured":"Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6(1):1\u20139.10.1227\/00006123-198001000-000017354892"},{"issue":"6","key":"b30","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/WNL.50.6.1699","article-title":"Arterial territories of the human brain: cerebral hemispheres","volume":"50","author":"Tatu L","year":"1998","unstructured":"Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50(6):1699\u20131708.10.1212\/WNL.50.6.16999633714"},{"issue":"1","key":"b31","series-title":"Neurosurgery","first-page":"1","article-title":"Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management","volume":"33","author":"Laumer R","year":"1993","unstructured":"Laumer R, Steinmeier R, G\u00f6nner F, Vogtmann T, Priem R, Fahlbusch R. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management. Neurosurgery. 1993;33(1):1\u20139.8355824"},{"issue":"4","key":"b32","series-title":"Clin Nucl Med","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00003072-199704000-00006","article-title":"Delayed ischemia due to cerebral vasospasm occult to transcranial Doppler. An important role for cerebral perfusion SPECT","volume":"22","author":"Lewis DH","year":"1997","unstructured":"Lewis DH, Newell DW, Winn HR. Delayed ischemia due to cerebral vasospasm occult to transcranial Doppler. An important role for cerebral perfusion SPECT. Clin Nucl Med. 1997;22(4):238\u2013240.909948010.1097\/00003072-199704000-00006"},{"issue":"8","key":"b33","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1161\/01.STR.0000133132.76983.8e","article-title":"Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage","volume":"35","author":"Rabinstein AA","year":"2004","unstructured":"Rabinstein AA, Friedman JA, Weigand SD,  Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004;35(8):1862\u20131866.1521815610.1161\/01.STR.0000133132.76983.8e"},{"issue":"6","key":"b34","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/00006123-200112000-00010","article-title":"Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging","volume":"49","author":"Shimoda M","year":"2001","unstructured":"Shimoda M, Takeuchi M, Tominaga J, Oda S, Kumasaka A, Tsugane R. Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery. 2001;49(6):1341\u20131350.10.1097\/00006123-200112000-0001011846933"},{"issue":"4","key":"b35","series-title":"Braz J Med Biol Res","doi-asserted-by":"publisher","first-page":"e10498","DOI":"10.1590\/1414-431x202010498","article-title":"Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis","volume":"54","author":"He J","year":"2021","unstructured":"He J, Zhang X, He W,  Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis. Braz J Med Biol Res. 2021;54(4):e10498.3365605510.1590\/1414-431x202010498"},{"issue":"3","key":"b36","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1227\/00006123-198803000-00006","article-title":"Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage","volume":"22","author":"Mee E","year":"1988","unstructured":"Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery. 1988;22(3):484\u2013491.328359510.1227\/00006123-198803000-00006"},{"issue":"5","key":"b37","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3171\/jns.1988.69.5.0683","article-title":"Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery","volume":"69","author":"Ohman J","year":"1988","unstructured":"Ohman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg. 1988;69(5):683\u2013686.10.3171\/jns.1988.69.5.06833054010"},{"issue":"4","key":"b38","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","article-title":"Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk KC","year":"1988","unstructured":"Petruk KC, West M, Mohr G,  Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988;68(4):505\u2013517.10.3171\/jns.1988.68.4.05053280746"},{"issue":"6674","key":"b39","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"Pickard JD","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R,  Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636\u2013642.10.1136\/bmj.298.6674.6362496789"},{"issue":"5","key":"b40","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3171\/jns.1996.84.5.0792","article-title":"Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial","volume":"84","author":"Asano T","year":"1996","unstructured":"Asano T, Takakura K, Sano K,  Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial. J Neurosurg. 1996;84(5):792\u2013803.862215310.3171\/jns.1996.84.5.0792"},{"issue":"3","key":"b41","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3171\/jns.1997.86.3.0467","article-title":"A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America","volume":"86","author":"Haley EC Jr","year":"1997","unstructured":"Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997;86(3):467\u2013474.10.3171\/jns.1997.86.3.04679046304"},{"issue":"10","key":"b42","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2176\/nmc.51.679","article-title":"Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine","volume":"51","author":"Zhao J","year":"2011","unstructured":"Zhao J, Zhou D, Guo J,  Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo).2011;51(10):679\u2013683.10.2176\/nmc.51.679"},{"issue":"1-2","key":"b43","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000445509","article-title":"Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Matsuda N","year":"2016","unstructured":"Matsuda N, Naraoka M, Ohkuma H,  Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. Cerebrovasc Dis. 2016;42(1-2):97\u2013105.10.1159\/00044550927070952"},{"issue":"3","key":"b44","series-title":"Aging (Albany NY)","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.18632\/aging.102788","article-title":"Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults","volume":"12","author":"Chen J","year":"2020","unstructured":"Chen J, Li M, Zhu X,  Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults. Aging (Albany NY). 2020;12(3):2939\u20132951.10.18632\/aging.102788"},{"issue":"1","key":"b1","series-title":"Neurol India","first-page":"185","article-title":"Cerebral vasospasm and delayed cerebral ischemia: review of literature and the management approach","volume":"67","author":"Chugh C","year":"2019","unstructured":"Chugh C, Agarwal H. Cerebral vasospasm and delayed cerebral ischemia: review of literature and the management approach. Neurol India. 2019;67(1):185\u2013200.30860121"},{"issue":"6","key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3171\/jns.2003.98.6.1222","article-title":"Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"98","author":"McGirt MJ","year":"2003","unstructured":"McGirt MJ, Mavropoulos JC, McGirt LY,  Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(6):1222\u20131226.10.3171\/jns.2003.98.6.122212816268"},{"issue":"3","key":"b3","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1227\/01.NEU.0000153925.96889.8A","article-title":"Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study","volume":"56","author":"Parra A","year":"2005","unstructured":"Parra A, Kreiter KT, Williams S,  Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery. 2005;56(3):476\u2013484.10.1227\/01.NEU.0000153925.96889.8A15730572"},{"issue":"8","key":"b4","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","article-title":"Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial","volume":"36","author":"Tseng MY","year":"2005","unstructured":"Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36(8):1627\u20131632.1604919910.1161\/01.STR.0000176743.67564.5d"},{"key":"b5","series-title":"J Neurol Sci","doi-asserted-by":"publisher","first-page":"116539","DOI":"10.1016\/j.jns.2019.116539","article-title":"Impaired cerebrovascular reactivity may predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"407","author":"B\u00f8thun ML","year":"2019","unstructured":"B\u00f8thun ML, Haaland \u00d8A, Moen G,  Impaired cerebrovascular reactivity may predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2019;407:116539.3166972510.1016\/j.jns.2019.116539"},{"key":"b6","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e913","DOI":"10.1016\/j.wneu.2020.03.146","article-title":"Cerebral vasospasm after spontaneous subarachnoid hemorrhage: angiographic pattern and its impact on the clinical course","volume":"138","author":"Ditz C","year":"2020","unstructured":"Ditz C, Leppert J, Neumann A,  Cerebral vasospasm after spontaneous subarachnoid hemorrhage: angiographic pattern and its impact on the clinical course. World Neurosurg. 2020;138:e913\u2013e921.10.1016\/j.wneu.2020.03.14632247799"},{"issue":"4","key":"b7","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1227\/01.NEU.0000137628.51839.D5","article-title":"Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage","volume":"55","author":"Hoh BL","year":"2004","unstructured":"Hoh BL, Topcuoglu MA, Singhal AB,  Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55(4):779\u2013789.1545858610.1227\/01.NEU.0000137628.51839.D5"},{"issue":"2","key":"b8","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00701-018-3765-8","article-title":"How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?","volume":"161","author":"Hollingworth M","year":"2019","unstructured":"Hollingworth M, Jamjoom AAB, Bulters D, Patel HC. How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?. Acta Neurochir (Wien). 2019;161(2):385\u2013392.10.1007\/s00701-018-3765-8"},{"key":"b9","series-title":"Acta Neurochir Suppl","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/3-211-27911-3_11","article-title":"Cerebral vasospasm: results of a structured multimodal treatment","volume":"94","author":"Keller E","year":"2005","unstructured":"Keller E, Krayenb\u00fchl N, Bjeljac M, Yonekawa Y. Cerebral vasospasm: results of a structured multimodal treatment. Acta Neurochir Suppl. 2005;94:65\u201373.1606024310.1007\/3-211-27911-3_11"},{"issue":"9","key":"b10","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","article-title":"Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited","volume":"32","author":"Claassen J","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K,  Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32(9):2012\u20132020.10.1161\/hs0901.09567711546890"},{"issue":"4","key":"b11","series-title":"Crit Care Med","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/00003246-200004000-00012","article-title":"Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"28","author":"Qureshi AI","year":"2000","unstructured":"Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA. Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med. 2000;28(4):984\u2013990.1080927010.1097\/00003246-200004000-00012"},{"issue":"1","key":"b12","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/neuros\/nyx364","article-title":"The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes","volume":"83","author":"Ahn SH","year":"2018","unstructured":"Ahn SH, Savarraj JP, Pervez M,  The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes. Neurosurgery. 2018;83(1):137\u2013145.10.1093\/neuros\/nyx36428973675"},{"issue":"6","key":"b13","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/jnnp.2003.033068","article-title":"Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?","volume":"75","author":"Goddard AJ","year":"2004","unstructured":"Goddard AJ, Raju PP, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?. J Neurol Neurosurg Psychiatry. 2004;75(6):868\u2013872.1514600210.1136\/jnnp.2003.033068"},{"issue":"2","key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2016.10.JNS16748","article-title":"Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis","volume":"129","author":"Dasenbrock HH","year":"2018","unstructured":"Dasenbrock HH, Rudy RF, Rosalind Lai PM,  Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis. J Neurosurg. 2018;129(2):446\u2013457.10.3171\/2016.10.JNS1674829076779"},{"issue":"4","key":"b15","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0230953","DOI":"10.1371\/journal.pone.0230953","article-title":"Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older","volume":"15","author":"Ido K","year":"2020","unstructured":"Ido K, Kurogi R, Kurogi A,  Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. PLoS One. 2020;15(4):e0230953.10.1371\/journal.pone.023095332271814"},{"issue":"6","key":"b16","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2176\/nmc.oa.2013-0169","article-title":"Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"54","author":"Inagawa T","year":"2014","unstructured":"Inagawa T, Yahara K, Ohbayashi N. Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2014;54(6):465\u2013473.10.2176\/nmc.oa.2013-0169"},{"issue":"2","key":"b17","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainres.2003.11.040","article-title":"Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats","volume":"999","author":"R\u00edos C","year":"2004","unstructured":"R\u00edos C, Nader-Kawachi J, Rodriguez-Pay\u00e1n AJ, Nava-Ruiz C. Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats. Brain Res. 2004;999(2):212\u2013215.10.1016\/j.brainres.2003.11.040"},{"issue":"1","key":"b18","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0090-3019(97)00508-9","article-title":"Effect of clot removal and surgical manipulation on regional cerebral blood flow and delayed vasospasm in early aneurysm surgery for subarachnoid hemorrhage","volume":"51","author":"Hosoda K","year":"1999","unstructured":"Hosoda K, Fujita S, Kawaguchi T, Shose Y, Hamano S, Iwakura M. Effect of clot removal and surgical manipulation on regional cerebral blood flow and delayed vasospasm in early aneurysm surgery for subarachnoid hemorrhage. Surg Neurol. 1999;51(1):81\u201388.10.1016\/S0090-3019(97)00508-99952128"},{"issue":"7","key":"b19","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/01.STR.30.7.1409","article-title":"Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans","volume":"30","author":"Thomas JE","year":"1999","unstructured":"Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke. 1999;30(7):1409\u20131416.1039031510.1161\/01.STR.30.7.1409"},{"issue":"8","key":"b20","series-title":"Eur Radiol","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s00330-016-4702-y","article-title":"Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis","volume":"27","author":"Boulouis G","year":"2017","unstructured":"Boulouis G, Labeyrie MA, Raymond J,  Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol. 2017;27(8):3333\u20133342.10.1007\/s00330-016-4702-y28004163"},{"key":"b21","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.wneu.2019.03.083","article-title":"A Review of the Management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"126","author":"Li K","year":"2019","unstructured":"Li K, Barras CD, Chandra RV,  A Review of the Management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513\u2013527.3089874010.1016\/j.wneu.2019.03.083"},{"issue":"2","key":"b22","series-title":"Platelets","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/09537104.2014.886677","article-title":"Dapsone for immune thrombocytopenic purpura in children and adults","volume":"26","author":"Patel AP","year":"2015","unstructured":"Patel AP, Patil AS. Dapsone for immune thrombocytopenic purpura in children and adults. Platelets. 2015;26(2):164\u2013167.10.3109\/09537104.2014.88667724512442"},{"issue":"2)(suppl 1","key":"b23","series-title":"An Bras Dermatol","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1590\/abd1806-4841.2019940206","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus\u2014Brazilian Society of Dermatology","volume":"94","author":"Porro AM","year":"2019","unstructured":"Porro AM, Hans Filho G, Santi CG. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus\u2014Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2)(suppl 1):20\u201332.10.1590\/abd1806-4841.201994020631166407"},{"issue":"8","key":"b24","series-title":"Eur J Pediatr","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00431-019-03409-5","article-title":"Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature","volume":"178","author":"Roman C","year":"2019","unstructured":"Roman C, Dima B, Muyshont L, Schurmans T, Gilliaux O. Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. Eur J Pediatr. 2019;178(8):1275\u20131281.10.1007\/s00431-019-03409-5"},{"issue":"5","key":"b25","series-title":"Br J Dermatol","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2133.2005.06559.x","article-title":"Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner","volume":"152","author":"Suda T","year":"2005","unstructured":"Suda T, Suzuki Y, Matsui T,  Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol. 2005;152(5):887\u2013895.10.1111\/j.1365-2133.2005.06559.x"},{"key":"b26","series-title":"Malar J","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-11-139","article-title":"Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria","volume":"11","author":"Van Malderen C","year":"2012","unstructured":"Van Malderen C, Van Geertruyden JP, Machevo S,  Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J. 2012;11:139.10.1186\/1475-2875-11-139"},{"issue":"4","key":"b27","series-title":"Electrophysiologic evaluation. Arch Med Res","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0188-4409(03)00045-6","article-title":"Anticonvulsant activity of dapsone analogs","volume":"34","author":"L\u00f3pez-Naranjo F","year":"2003","unstructured":"L\u00f3pez-Naranjo F, Casta\u00f1eda-L\u00f3pez C, Rojas-Oviedo I,  Anticonvulsant activity of dapsone analogs. Electrophysiologic evaluation. Arch Med Res. 2003;34(4):269\u2013272.10.1016\/S0188-4409(03)00045-612957521"},{"issue":"11","key":"b28","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/jnnp.51.11.1457","article-title":"A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies","volume":"51","author":"Teasdale GM","year":"1988","unstructured":"Teasdale GM, Drake CG, Hunt W,  A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51(11):1457.323602410.1136\/jnnp.51.11.1457"},{"issue":"1","key":"b29","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","author":"Fisher CM","year":"1980","unstructured":"Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6(1):1\u20139.10.1227\/00006123-198001000-000017354892"},{"issue":"6","key":"b30","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/WNL.50.6.1699","article-title":"Arterial territories of the human brain: cerebral hemispheres","volume":"50","author":"Tatu L","year":"1998","unstructured":"Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50(6):1699\u20131708.10.1212\/WNL.50.6.16999633714"},{"issue":"1","key":"b31","series-title":"Neurosurgery","first-page":"1","article-title":"Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management","volume":"33","author":"Laumer R","year":"1993","unstructured":"Laumer R, Steinmeier R, G\u00f6nner F, Vogtmann T, Priem R, Fahlbusch R. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management. Neurosurgery. 1993;33(1):1\u20139.8355824"},{"issue":"4","key":"b32","series-title":"Clin Nucl Med","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00003072-199704000-00006","article-title":"Delayed ischemia due to cerebral vasospasm occult to transcranial Doppler. An important role for cerebral perfusion SPECT","volume":"22","author":"Lewis DH","year":"1997","unstructured":"Lewis DH, Newell DW, Winn HR. Delayed ischemia due to cerebral vasospasm occult to transcranial Doppler. An important role for cerebral perfusion SPECT. Clin Nucl Med. 1997;22(4):238\u2013240.909948010.1097\/00003072-199704000-00006"},{"issue":"8","key":"b33","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1161\/01.STR.0000133132.76983.8e","article-title":"Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage","volume":"35","author":"Rabinstein AA","year":"2004","unstructured":"Rabinstein AA, Friedman JA, Weigand SD,  Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004;35(8):1862\u20131866.1521815610.1161\/01.STR.0000133132.76983.8e"},{"issue":"6","key":"b34","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/00006123-200112000-00010","article-title":"Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging","volume":"49","author":"Shimoda M","year":"2001","unstructured":"Shimoda M, Takeuchi M, Tominaga J, Oda S, Kumasaka A, Tsugane R. Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery. 2001;49(6):1341\u20131350.10.1097\/00006123-200112000-0001011846933"},{"issue":"4","key":"b35","series-title":"Braz J Med Biol Res","doi-asserted-by":"publisher","first-page":"e10498","DOI":"10.1590\/1414-431x202010498","article-title":"Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis","volume":"54","author":"He J","year":"2021","unstructured":"He J, Zhang X, He W,  Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis. Braz J Med Biol Res. 2021;54(4):e10498.3365605510.1590\/1414-431x202010498"},{"issue":"3","key":"b36","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1227\/00006123-198803000-00006","article-title":"Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage","volume":"22","author":"Mee E","year":"1988","unstructured":"Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery. 1988;22(3):484\u2013491.328359510.1227\/00006123-198803000-00006"},{"issue":"5","key":"b37","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3171\/jns.1988.69.5.0683","article-title":"Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery","volume":"69","author":"Ohman J","year":"1988","unstructured":"Ohman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg. 1988;69(5):683\u2013686.10.3171\/jns.1988.69.5.06833054010"},{"issue":"4","key":"b38","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","article-title":"Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk KC","year":"1988","unstructured":"Petruk KC, West M, Mohr G,  Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988;68(4):505\u2013517.10.3171\/jns.1988.68.4.05053280746"},{"issue":"6674","key":"b39","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"Pickard JD","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R,  Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636\u2013642.10.1136\/bmj.298.6674.6362496789"},{"issue":"5","key":"b40","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3171\/jns.1996.84.5.0792","article-title":"Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial","volume":"84","author":"Asano T","year":"1996","unstructured":"Asano T, Takakura K, Sano K,  Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial. J Neurosurg. 1996;84(5):792\u2013803.862215310.3171\/jns.1996.84.5.0792"},{"issue":"3","key":"b41","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3171\/jns.1997.86.3.0467","article-title":"A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America","volume":"86","author":"Haley EC Jr","year":"1997","unstructured":"Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997;86(3):467\u2013474.10.3171\/jns.1997.86.3.04679046304"},{"issue":"10","key":"b42","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2176\/nmc.51.679","article-title":"Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine","volume":"51","author":"Zhao J","year":"2011","unstructured":"Zhao J, Zhou D, Guo J,  Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo).2011;51(10):679\u2013683.10.2176\/nmc.51.679"},{"issue":"1-2","key":"b43","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000445509","article-title":"Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Matsuda N","year":"2016","unstructured":"Matsuda N, Naraoka M, Ohkuma H,  Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. Cerebrovasc Dis. 2016;42(1-2):97\u2013105.10.1159\/00044550927070952"},{"issue":"3","key":"b44","series-title":"Aging (Albany NY)","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.18632\/aging.102788","article-title":"Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults","volume":"12","author":"Chen J","year":"2020","unstructured":"Chen J, Li M, Zhu X,  Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults. Aging (Albany NY). 2020;12(3):2939\u20132951.10.18632\/aging.102788"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/52\/3\/article-pE12.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/52\/3\/article-pE12.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/52\/3\/article-pE12.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:28:05Z","timestamp":1780734485000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/52\/3\/article-pE12.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":88,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2021.12.focus21663","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}